GO
Loading...

Jamie Dimon's cancer sparks successor question

Though JPMorgan Chase CEO Jamie Dimon characterized his throat cancer as "curable," it's "not exploitative" to think about his successor, Jeffrey Sonnenfeld, a professor at the Yale School of Management, told CNBC on Wednesday.

Read MoreJamie Dimon says he has 'curable' throat cancer

In a note to staff, Dimon said his cancer is believed to be contained in his throat and lymph nodes on his right side. The 58-year-old plans to remain actively involved in the largest U.S. bank's business, even as he undergoes radiation and chemotherapy treatment that is expected to last about eight weeks.

While the prognosis for Dimon's recovery is good, JPMorgan's board of directors should consider a succession plan, Sonnenfeld said on "Squawk Box."

After all, Dimon is such a strong leader that if JPMorgan does not consider who will follow him, the banking giant could lose its way.

"It is not exploitative, I think, to take a look and make sure this board has deep bench strength and they do," he said.

Possible successors include Gordon Smith, CEO of consumer banking, Mary Erdoes, CEO of asset management and Daniel Pinto, CEO of corporate and investment banking.

To Sonnenfeld, Dimon has done a good job of raising the profile of these executives. But in any case, Dimon will be a "tough act to follow."

"He is absolutely iconic. He is probably the most feared and revered man in finance today. ... He has proven himself many times over," Sonnenfeld said. "He's a comeback superstar in his personal career and also in the, what, 48 percent return in stock price in this company and despite the crazy pounding of some of those penalties they had to withstand. Still, they turned out record profits."

—By CNBC's Drew Sandholm.

Symbol
Price
 
Change
%Change
JPM
---

Featured

Banks